Vol 15, No 4 (August 31, 2026): Chinese Clinical Oncology

Original Article

Preliminary study on efficacy and safety of pixantrone in relapsed/refractory aggressive B-cell lymphomas: multicenter, retrospective cohort study by Polish Lymphoma Research Group (PLRG)
Magdalena Witkowska, Sebastian Szmit, Agnieszka Kołkowska-Leśniak, Bartłomiej Kuszczak, Renata Kasza, Anna Koclęga, Oliwia Bachanek-Mitura, Dariusz Wołowiec
Chinese Clinical Oncology  
2026;
15
(4)
:56
.
A nomogram integrating clinical and multimodal ultrasound features for pretreatment prediction of HER2 status in breast cancer: a retrospective study
Xiao-Kai Lu, Jin-Dan Li, Dong Chen, Nian-Qiu Liu, Zhi-Rui Chuan, Yin-Xi Qu, Ying-Xian Zhang, Zhi-Yao Li, Hai-Tao Chen, Xiao-Mao Luo
Chinese Clinical Oncology  
2026;
15
(4)
:57
.
Research progress and trends in clinical trials for older people with colorectal cancer from 2005 to 2025: a bibliometric analysis
Jing Dong, Shanshan Gu, Yumei Zeng, Jiyan Shi, Yidan Hu, Zipei Zhang, Li Fu, Jiayi Song, Yun Xu
Chinese Clinical Oncology  
2026;
15
(4)
:58
.
Improving Asian American lung cancer screening awareness through virtual physician-led community outreach: quality improvement initiative
Elaine Liang, Amelia Wong, Jack R. Heckl, Michelle Kimura, Barkha Trivedi, Kenny Nguyen, Marikit Flores, Emily Nguyen, Peter Le, Janet Lai, Jeffrey B. Velotta
Chinese Clinical Oncology  
2026;
15
(4)
:59
.

Letter to the Editor

An interview-based study of Asian American non-smoker lung cancer in the United States
Grace Wang, Bryant Lin, Jeffrey B. Velotta
Chinese Clinical Oncology  
2026;
15
(4)
:64
.